Insulet Corporation - Common Stock (NQ:PODD)

Discover how Insulet Corp exemplifies a powerful growth investing system, showcasing strong earnings, soaring sales, and impressive cash flow.

Topics Stocks

Insulet Corp (NASDAQ:PODD) Passes Stringent Growth Screen ↗

November 10, 2025

Via Chartmill

Gapping S&P500 stocks in Thursday's session ↗

November 06, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.

Via Chartmill

Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter ↗

November 06, 2025

Insulet stock rose moderately early Thursday as its insulin pump, Omnipod, delivered double-digit growth in the U.S. and abroad.

Via Investor's Business Daily

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Price Over Earnings Overview: Insulet ↗

September 30, 2025

Via Benzinga

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

November 06, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Insulet’s (NASDAQ:PODD) Q3: Strong Sales

November 06, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 29.9% year on year to $706.3 million. On top of that, next...

Insulet Reports Third Quarter 2025 Results

November 06, 2025

Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade.

Examining the Future: Insulet's Earnings Outlook ↗

November 05, 2025

Via Benzinga

Insulet, Uber And A Financial Stock On CNBC's 'Final Trades' ↗

November 05, 2025

Via Benzinga

Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow

November 04, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting results this Thursday before market hours. Here’s what investors should know.

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Peering Into Insulet Corp's Recent Short Interest ↗

October 31, 2025

Via Benzinga

$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

October 30, 2025

Via Benzinga

October 30, 2025

Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors.

INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum ↗

October 29, 2025

Via Chartmill

1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off

October 27, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers.

INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing ↗

October 25, 2025

Via Chartmill

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

October 23, 2025

Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth.

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗

October 21, 2025

Via Benzinga

Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD) ↗

October 20, 2025

Via Chartmill

Insulet to Host Investor Day on November 20, 2025

October 10, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Discover which S&P500 stocks are making waves on Thursday. ↗

October 09, 2025

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

October 01, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 29, 2025

Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization...

Via Benzinga

A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts ↗

September 29, 2025

6 analysts have shared their evaluations of Insulet (NASDAQ: PODD) during the recent three months, expressing a mix of bullish and bearish perspectives.

Via Benzinga

Insulet Corp (NASDAQ:PODD): An Affordable Growth Stock with Strong Profitability ↗

September 27, 2025

Insulet Corp (PODD) exemplifies affordable growth with strong revenue & EPS expansion, high profitability, and a valuation justified by its industry-leading potential.

Via Chartmill

Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Topics World Trade

Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today ↗

September 19, 2025

Via Benzinga

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

September 18, 2025